In the media

<p>Núria López-Bigas, head of the Biomedical Genomics Lab at IRB Barcelona</p>
27 Jan 2020 -

The newspapers La Gaceta de Salamanca and Tribuna Universitaria have interviewed Núria López-Bigas, ICREA researcher and head of the Biomedical Genomics Lab at the Institute for Research in Biomedicine (IRB Barcelona), on the occasion of the award of the “Doctores Diz Pintado” Prize, which she will receive in person on 28 January.  López-Bigas is the first female scientist to be presented with this prize. Referring to this point, the researcher says, “It is an honour to receive the prize. Being the first woman to do so highlights just how much work has to be done to achieve equality with respect to appraisement and visibility”.

<p>Manuel Serrano, head of the Cell Plasticity and Disease Laboratory at IRB Barcelona</p>
27 Jan 2020 -

The newspapers El Punt AVUI and Diari de Girona have interviewed Manuel Serrano, ICREA researcher and head of the Cell Plasticity and Disease Laboratory at IRB Barcelona, about the current projects underway in his group. In Serrano’s words, this laboratory “is working on finding new compounds—experimental drugs—that kill these cells (senescent cells)". The objective of this research is to understand why aging happens.

 

link to: Diari de Girona

link to:...

<p>ICREA researcher at IRB Barcelona, , Salvador Aznar</p>
24 Jan 2020 -

The newspaper La Vanguardia has published an article on accelerated and premature greying of hair. In a study performed with mice, scientists have observed that stress overactivates certain nerves of the autonomic nervous system, which in turn cause permanent damage to the stem cells responsible for regenerating hair pigment.

Referring to grey hair, Salvador Aznar, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona), says, “It is a clear message that you are sending to those around you, so it probably confers an evolutionary advantage”,

Link to: ...

<p>ICREA researcher at IRB Barcelona, Ángel Nebreda</p>
24 Jan 2020 -

Several media outlets have reported on a study led Angel Nebreda, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona). In this work, his team has observed that p38 inhibition causes a dramatic reduction in the growth and aggressiveness of lung tumours.

Link to: La Vanguardia

Link to: ABC

Link to :...

<p>Manuel Serrano, ICREA researcher at IRB Barcelona</p>
21 Jan 2020 -

The radio programme La Tarde broadcasted by COPE has interviewed Manuel Serrano, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona), about human aging.  Serrano emphasizes that one of the basic aspects of aging is childhood health. “Development is affected in a child that has had many diseases or infections.  It is believed that periods of ill health have future consequences”, said the researcher. 

15 Jan 2020 -

The newspaper La Vanguardia has published two articles about the most recent work done by Joan Massagué, Director of the Sloan Kettering Institute, co-founder of the Institute for Research in Biomedicine (IRB Barcelona) and current chair of its External Advisory Board. In a study published in the journal Nature Cancer, Massagué reveals the mechanism that gives rise to metastasis. This discovery marks the culmination of a line of research that was started about 20 years ago. The study describes in detail how cancer cells stealthily use a mechanism that repairs and has beneficial effects in healthy tissues.

The article in La Vanguardia includes the expert opinions of Roger Gomis and...

<p>Image created by computer of a liver cancer (SEBASTIAN KAULITZKI/SCIENCE PHOT / Getty)</p>
13 Jan 2020 -

The Preguntas Big Van section of La Vanguardia has published an article on a new joint project being done by Raúl Méndez, group leader at the Institute for Research in Biomedicine (IRB Barcelona), together with Mercedes Fernández, researchers at the Instituto de Investigaciones Biomédicas August Pi i Sunyer.

This project seeks to analyse the cells that regulate the activity of genes (CPEB) during liver cancer development.  “We aim to unravel the mechanisms through which CPEBs contribute to tumour onset and growth,” explains Méndez. “If we understand these mechanisms then we might be able to develop pharmacological treatment to prevent or better treat liver cancer”.

This...

<p>The ICREA  researcher and head of Colorectal Cancer Lab.</p>
13 Jan 2020 -

La Razón has published an article about a study addressing the involvement of fibroblasts in colon cancer being carried out by "La Caixa" and the Colorectal Cancer Lab, headed by Eduard Batlle, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona). 

Colon cancer is one of the most frequent types of cancer, and although treatment cures this disease for most patients, a large percentage develop metastases in vital organs.  In this regard, immunotherapy is not effective for this kind of cancer, benefiting only 5% of patients. This is because the colon cancer cells develop a mechanism through which to evade the immune system. “Understanding the...

<p>Robert Soliva and Modesto Orozco with their team (César Rangel)</p>
8 Jan 2020 -

La Vanguardia has devoted an article to the Senén Vilaró Prize for the best innovative company, which has recently been awarded to Nostrum Biodiscovery (NBD). This prize acknowledges the capacity of the technology developed by this company to allow pharmaceutical companies to speed up drug discovery and reduce the costs involved.

NBD was founded in 2016 as a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center (BSC-CNS), with the objective to support the discovery and launch of new drugs and biotech molecules. Modesto Orozco, head of Molecullar Modelling and Bioinformatics lab and holder of an ERC Advanced Grant at IRB...

<p>Manuel Serrano, ICREA researcher at IRB Barcelona</p>
8 Jan 2020 -

Manuel Serrano, ICREA researcher at IRB Barcelona, participated in the programme Inmortals, broadcasted on TV3, in which he talked about aging. The slowing down of aging in mouse has been achieved.  It is now only a question of time until the resources are available to reverse aging and increase lifespan in humans.  In this regard, Serrano says, “I don’t know whether the limit will be 120 or 140 years, but I am sure lifespan will increase"

 

Link to TV3